Engrave Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-676
Closed -$159K 68
2020
Q2
$159K Buy
676
+47
+7% +$10.7K 0.14% 58
2020
Q1
$127K Buy
629
+25
+4% +$5.46K 0.15% 52
2019
Q4
$145K Buy
+604
New +$133K 0.14% 59

Other funds holding AMGN

Engrave Wealth Partners's AMGN Position: Q3 2020 in Review

Engrave Wealth Partners sold out of Amgen (AMGN) in Q3 2020, closing a stake of 676 shares — an estimated $159K sold.

Engrave Wealth Partners first reported a position in AMGN in Q4 2019 and held it in 3 quarters. The position peaked at $159K in Q2 2020. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Engrave Wealth Partners reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 676 Amgen shares in Q3 2020, an estimated $159K.
  • Engrave Wealth Partners first reported a position in Amgen in Q4 2019 and held it in 3 quarters.
  • Engrave Wealth Partners's Amgen position peaked at $159K in Q2 2020.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Engrave Wealth Partners's 13F filing for Q3 2020, filed 8 Oct 2020.